Takuya Miyamoto Selected Research

ErbB Receptors (EGF Receptor)

1/2020	Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin.
5/2016	Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takuya Miyamoto Research Topics

Disease

21	Heart Failure 12/2021 - 05/2003
17	Cardiovascular Diseases (Cardiovascular Disease) 02/2018 - 02/2005
6	Peripheral Arterial Disease 01/2018 - 01/2015
6	Atrial Fibrillation 01/2016 - 07/2006
5	Stroke (Strokes) 01/2023 - 05/2012
5	Spinal Cord Diseases 01/2022 - 01/2018
5	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2003
5	Myocardial Infarction 07/2018 - 12/2003
4	Coronary Artery Disease (Coronary Atherosclerosis) 08/2016 - 04/2014
4	Inflammation (Inflammations) 04/2014 - 09/2008
4	Death (Near-Death Experience) 07/2012 - 02/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 01/2011
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2021 - 10/2021
2	Mycoses (Diseases, Fungus) 01/2021 - 10/2020
2	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2019 - 01/2011
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2018 - 01/2011
2	Anemia 02/2018 - 05/2014
2	Atherosclerosis 01/2018 - 01/2016
2	Diabetes Mellitus 01/2018 - 01/2014
2	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 12/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 05/2003
2	Acute Coronary Syndrome 12/2017 - 09/2014
2	Stable Angina 12/2017 - 09/2014
2	Chronic Limb-Threatening Ischemia 02/2017 - 12/2015
2	Shock 12/2016 - 03/2016
2	Insulin Resistance 08/2016 - 04/2014
2	Hypertrophy 05/2016 - 09/2013
2	Chronic Renal Insufficiency 05/2016 - 01/2011
2	Heart Injuries 03/2016 - 07/2012
2	Cardiotoxicity 01/2016 - 05/2015
2	Cardiomyopathies (Cardiomyopathy) 05/2015 - 07/2012
2	Sarcopenia 03/2015 - 01/2015
2	Obesity 05/2014 - 01/2014
2	Body Weight (Weight, Body) 02/2014 - 01/2011
2	Ventricular Remodeling 12/2003 - 11/2002
1	Neck Pain (Cervicalgia) 01/2022
1	Lordosis 01/2022
1	Neutropenia 12/2021
1	Hyperuricemia 12/2021
1	Neurilemmoma (Schwannoma) 05/2020
1	Meningioma (Meningiomas) 05/2020
1	Pulmonary Hypertension 01/2020
1	Aortic Valve Insufficiency (Aortic Regurgitation) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Pulmonary Arterial Hypertension 01/2020
1	Right Ventricular Hypertrophy 01/2020
1	Vascular Remodeling 01/2020

Drug/Important Bio-Agent (IBA)

11	Fatty Acid Binding Protein 3IBA 02/2018 - 02/2005
7	Fatty Acid-Binding ProteinsIBA 02/2018 - 02/2005
5	Biomarkers (Surrogate Marker)IBA 04/2020 - 11/2008
5	Proteins (Proteins, Gene)FDA Link 04/2016 - 02/2004
4	MidkineIBA 01/2020 - 04/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 07/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2014
3	Cystatin CIBA 10/2016 - 01/2011
3	Troponin T (Troponin T1)IBA 03/2016 - 07/2012
3	Messenger RNA (mRNA)IBA 01/2016 - 12/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2011
3	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2014 - 11/2008
2	Uric Acid (Urate)IBA 12/2021 - 08/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 05/2016
2	Xanthine DehydrogenaseIBA 01/2019 - 02/2017
2	LipidsIBA 12/2017 - 01/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017 - 09/2014
2	CollagenIBA 02/2017 - 01/2016
2	Collagen Type I (Type I Collagen)IBA 02/2017 - 12/2003
2	CreatinineIBA 10/2016 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 05/2015
2	ThioredoxinsIBA 01/2016 - 11/2014
2	HMGB1 Protein (HMG1)IBA 05/2015 - 09/2013
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2015 - 10/2011
2	AdipokinesIBA 05/2014 - 04/2014
2	EnzymesIBA 07/2011 - 02/2005
2	ImmunosorbentsIBA 07/2011 - 02/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2008 - 12/2003
1	CytokinesIBA 12/2021
1	Allopurinol (Remid)FDA LinkGeneric 12/2021
1	Febuxostat FDA Link 12/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	SA 4503IBA 10/2021
1	Therapeutic UsesIBA 10/2021
1	AlbuminsIBA 08/2021
1	PotassiumIBA 08/2021
1	mefentrifluconazoleIBA 01/2021
1	2- chloro- N- (4- chlorobiphenyl- 2- yl)nicotinamideIBA 10/2020
1	CalciumIBA 01/2020
1	NucleolinIBA 01/2020
1	AGRO 100IBA 01/2020
1	locked nucleic acidIBA 01/2020

Therapy/Procedure

10	Therapeutics 12/2021 - 01/2015
5	Patient Readmission 07/2018 - 02/2005
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2016 - 01/2011
3	Secondary Prevention 12/2017 - 05/2012
3	Catheter Ablation 01/2016 - 01/2011
3	Percutaneous Coronary Intervention 01/2015 - 01/2013
2	Activities of Daily Living (ADL) 01/2023 - 01/2022
2	Laminoplasty 01/2022 - 10/2020
2	Decompression 10/2020 - 04/2020
2	Aftercare (After-Treatment) 01/2020 - 07/2006
1	Operative Surgical Procedures 05/2020